Search results
Results From The WOW.Com Content Network
There are 14 global core medicines that enable international comparisons, 16 regional core medicines that enable regional comparisons, and 20 supplementary medicines that are locally important. When comparing prices, one dosage form and strength is specified for each medicine. To calculate affordability, a typical treatment schedule is specified.
Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales. Abbreviations are used in the list as follows: INN = International Nonproprietary Name
The drug policy of the Philippines is guided by the Comprehensive Dangerous Drugs Act of 2002 and is implemented by the Dangerous Drugs Board with its implementing arm, the Philippine Drug Enforcement Agency along with other member agencies. Aside from regulating and prohibiting the usage, sale, production of certain drugs, the 2002 law is ...
International Medical Products Price Guide, formerly known as International Drug Price Indicator Guide, lists drug price information for WHO Essential Medicines. [1] It is maintained by Management Sciences for Health (MSH) on behalf of the World Health Organization . [ 1 ]
The Philippine Senate Committee on Public Order and Dangerous Drugs is a standing committee of the Senate of the Philippines. It was known as the Committee on Public Order and Illegal Drugs until November 9, 2010.
Medication costs can be the selling price from the manufacturer, that price together with shipping, the wholesale price, the retail price, and the dispensed price. [3]The dispensed price or prescription cost is defined as a cost which the patient has to pay to get medicines or treatments which are written as directions on prescription by a prescribers. [4]
The Comprehensive Dangerous Drugs Act of 2002, officially designated as Republic Act No. 9165, is a consolidation of Senate Bill No. 1858 and House Bill No. 4433.It was enacted and passed by the Senate of the Philippines and House of Representatives of the Philippines on May 30 and 29, 2002, respectively.
[2] [3] In 2012, the United Nations said the Philippines had the highest rate of methamphetamine use in East Asia, and according to a U.S. State Department report, 2.1 percent of Filipinos aged 16 to 64 use the drug [4] based on 2008 figures by the Philippines Dangerous Drugs Board. [5]